Vifor Pharma (GNHAF) Stock Price, News & Analysis

Company Overview

Vifor Pharma was a Switzerland-based specialty pharmaceutical company focused on treatments for iron deficiency, anemia, and kidney-related disorders. Its portfolio included intravenous iron products such as Ferinject, marketed as Injectafer in the United States, and Venofer, as well as therapies and services supporting patients with chronic kidney disease and those receiving dialysis.

The company developed, manufactured, and commercialized prescription medicines through direct operations and partnerships in international markets, including Europe, North America, and other global regions. Vifor Pharma also worked with healthcare providers and dialysis organizations to improve the management of iron deficiency and anemia associated with chronic disease.

Vifor Pharma was formerly known as Galenica and was headquartered in St. Gallen, Switzerland. CSL completed its acquisition of Vifor Pharma in 2022, after which the business became part of CSL’s specialty pharmaceutical operations and was branded CSL Vifor.

Key Stats

• Today's Range: $181.25 to $181.25
• 50-Day Range: $181.25 to $181.25
• 52-Week Range: $174.25 to $183.50
• Volume: N/A
• Average Volume: 100 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:GNHAF
• CIK: N/A
• Web: www.viforpharma.com
• Phone: (158) 851-8000
• Fax: N/A
• Employees: 2,200
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A